Answers are grounded in this paper and cite their sources.
Reveals miR-628-3p promotes inflammation in allergic rhinitis, highlighting its mechanistic role.
BACKGROUND: Allergic Rhinitis (AR) represents a widespread chronic inflammatory condition, with especially prevalence observed in children and urban populations. AIM: This study primarily explored the expression of miR-628-3p in AR and its functional implications on the inflammatory response, and elucidated the underlying molecular mechanisms through which miR-628-3p regulates AR. METHODS: RT-qPCR analysis quantified miR-628-3p expression in AR patient serum and cell models. The biological functionality of the cells was assessed using the CCK-8 assay and flow cytometry. Inflammatory cytokine levels were measured via ELISA. Bioinformatic prediction and dual-luciferase reporter assays were employed to validate miR-628-3p targets. RESULTS: miR-628-3p expression was upregulated in the serum and cell samples of AR compared to healthy controls. miR-628-3p can target and bind to the downstream CELF2. Downregulation of miR-628-3p reduced apoptosis in AR cells and suppressed levels of inflammatory factors, while transfection of si-CELF2 reversed the protective ability of miR-628-3p inhibitor on AR cells. CONCLUSIONS: Knockdown of miR-628-3p may contribute to the pathogenesis of AR by mediating CELF2 to reduce the apoptosis and inflammatory response of AR cells, suggesting its potential protective role against AR-related cellular damage.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: